Yahoo · Oct 9, 2026
Should You Buy, Hold or Sell Tempus AI Stock Amid AI Boom?
TEM's strong data licensing growth, AI-driven innovations and rising shares favor holding the stock, but premium valuation and reimbursement risks warrant caution.
CT
NASDAQ · CTEV
Claritev Corporation
Healthcare · Medical - Healthcare Information Services
$23.94
Up+$0.22 (+0.93%)
Updated Oct 15, 2026, 11:12 AM
SID Score
5.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 641.19M
- P/E ratio
- -1.87
- Dividend yield
- 0.00%
- 52-week range
- $11.50 – $42.47
- Volume
- 184.32K
- Avg. volume
- 180.27K
Price performance · CTEV
CTEV price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 14, 2026
CTEV closed at $23.94 after 21 trading sessions, down 28.67% for the selected period.
- Last close
- $23.94
- Period change
- -28.67%
- Period low
- $21.17
- Period high
- $33.56
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 14, 2026 | $22.95 | $24.00 | $22.425 | $23.94 | 184.32K |
| Oct 13, 2026 | $24.50 | $24.50 | $23.63 | $23.72 | 121.5K |
| Oct 12, 2026 | $24.83 | $24.83 | $24.08 | $24.33 | 118.79K |
| Oct 9, 2026 | $24.51 | $25.33 | $24.51 | $24.66 | 126.75K |
| Oct 8, 2026 | $24.84 | $24.84 | $23.65 | $24.33 | 245.15K |
| Oct 7, 2026 | $23.52 | $25.69 | $23.36 | $25.03 | 216.22K |
| Oct 6, 2026 | $25.05 | $25.05 | $23.01 | $24.09 | 189.12K |
| Oct 5, 2026 | $23.77 | $24.785 | $22.69 | $24.68 | 223.33K |
| Oct 2, 2026 | $21.97 | $23.92 | $21.32 | $23.72 | 228.9K |
| Oct 1, 2026 | $21.01 | $21.335 | $20.24 | $21.31 | 188.76K |
| Sep 30, 2026 | $21.43 | $21.985 | $20.88 | $21.17 | 230.38K |
| Sep 29, 2026 | $22.13 | $22.31 | $21.07 | $21.64 | 197.41K |
| Sep 28, 2026 | $22.73 | $23.70 | $22.10 | $22.47 | 137.34K |
| Sep 25, 2026 | $23.17 | $24.29 | $22.30 | $23.20 | 201.4K |
| Sep 24, 2026 | $24.29 | $25.40 | $23.16 | $23.36 | 151.26K |
| Sep 23, 2026 | $28.82 | $28.82 | $25.04 | $25.04 | 174.29K |
| Sep 22, 2026 | $32.59 | $33.31 | $29.03 | $29.45 | 176.43K |
| Sep 21, 2026 | $31.36 | $31.68 | $30.07 | $31.62 | 184.65K |
| Sep 18, 2026 | $31.81 | $32.03 | $30.81 | $30.81 | 305.22K |
| Sep 17, 2026 | $34.25 | $34.26 | $31.52 | $31.73 | 187.92K |
| Sep 16, 2026 | $35.24 | $35.67 | $33.50 | $33.56 | 99.13K |
Latest CTEV news
The latest Smart Investors Daily articles mentioning CTEV.
Stock researchCompany · Overview
Company
Market Activity
Research & News
CTEV research
Overview
Company profile and research snapshot.
Company profile
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- —
- Implied upside
- —
- Analysts
- 9
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 21, 2026 | Barclays | Overweight | — |
| Aug 12, 2026 | Wells Fargo | Equal-Weight | — |
| Aug 10, 2026 | Citigroup | Buy | — |
| Aug 10, 2026 | Canaccord Genuity | Buy | — |
| Jul 21, 2026 | Canaccord Genuity | Buy | — |
News briefing
No generated briefing is available yet.
SeekingAlpha · Oct 6, 2026
Claritev: Revenue Growth Is Back, Cash Flow Is The Next Test
Claritev shows early turnaround with revenue/bookings growth; Buy rating and $34 target (+40%). Click here to read this most recent analysis of CTEV stock.
Yahoo · Sep 22, 2026
Claritev Selected by GDIT to Support CDC’s World Trade Center Health Program
MCLEAN, Va., September 22, 2026--Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable, transparent and fair for all, has been selected by General Dynamics Information Technology (GDIT) to support the World Trade Center (WTC) Health Program. The WTC Health Program is a limited federal health care program established under the James Zadroga 9/11 Health and Compensation Act of 2010 (Extended in 2015). It provides nationw
Benzinga · Sep 22, 2026
Claritev Selected By General Dynamics Information Technology To Support The World Trade Center Health Program; Terms Not Disclosed
The WTC Health Program is a limited federal health care program established under the James Zadroga 9/11 Health and Compensation Act of 2010 (Extended in 2015). It provides nationwide medical monitoring and treatment to
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
